Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

How To Hedge Your Investing Ahead Of COVID’s 5th Wave

By David WooStock MarketsOct 21, 2021 12:54
uk.investing.com/analysis/how-to-hedge-your-investing-ahead-of-covids-5thwave-200500193
How To Hedge Your Investing Ahead Of COVID’s 5th Wave
By David Woo   |  Oct 21, 2021 12:54
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Financial markets seem to be operating under the assumption that COVID is under control and the pandemic is fading.

Daily Global New Confirmed COVID Cases
Daily Global New Confirmed COVID Cases

Charts: courtesy David Woo

Over the past six weeks, investors have been celebrating the tumbling numbers of new COVID cases around the world by moving their money out of vaccine stocks (e.g., Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) and into what the market has been calling re-opening stocks (e,g., restaurants, hotels, leisure), sectors that will benefit as the world returns to what we remember as the old normal.

That may be a mistake.

Humans are optimistic by nature. Most people, thirsting for the day that normal life returns, want to believe that science has triumphed over disease. And most investors, even big institutional ones, are only human.

So am I, but I'm also a contrarian. I like to find flaws in other people’s logic. In fact, I built a career on Wall Street betting against popular but flawed views.

And I believe the market is ignoring the two most important lessons we have learned from the pandemic so far:

  1. COVID-19, like all RNA viruses, has a propensity for mutation. The variant that was responsible for each of the past 4 waves was more virulent and more contagious than the previous one. It seems reasonable to assume that it is only a question of when before we see new variants against which the existing vaccines will prove ineffective.
  2. Even though 40% of the world’s population is now fully vaccinated, the effectiveness of the vaccine wanes over time. During this summer, Israel, the first country in the world to reach 50% vaccination rate, saw a resurgence of the pandemic that forced the country into another shutdown. At one point 60% of the hospitalized patients had been fully vaccinated.

Israel’s experience shows that the effectiveness of the vaccines (Pfizer specifically) wanes after 5-6 months. If we take that as a given, then it is reasonable to conclude that at this point the majority of fully vaccinated Americans have now lost protection from the vaccines.

Share of Population Fully Vaccinated
Share of Population Fully Vaccinated

This should be concerning. The arrival of colder weather means people will spend more time indoors while the onset of the accompanying flu season will leave their immune system weakened.

Meanwhile, Americans have let down their guard: schools have re-opened and mask requirements have been dropped in most US states. Even more crucially, the US Food and Drug Administration (FDA) has decided to recommend administering the booster vaccine only to those over the age of 65 as opposed to Israel, where anyone over the age 12 can get it, and to the UK, where the boosters are available to people over 50.

I hope I am wrong, but I believe the market is underestimating the risk that we will soon see a fifth COVID wave in the US.

Evidence suggests that the dynamic I fear is not hypothetical. Indeed, my analysis shows that on average, US states with a relatively low share of their population vaccinated over the past 5 months are currently seeing a higher number of new infections than those states with a relatively larger share of their population vaccinated over the last 5 months.

Relationship Between New Cases and Vaccination Rate
Relationship Between New Cases and Vaccination Rate

Over the next month, unless the FDA changes its booster guideline, most US states will see the level of their fully vaccinated population converge to those of Montana, Wyoming and Alaska today.

Reinforcing my view is the fact that new COVID cases are picking up even in states with a very high vaccination rate. For example, Vermont, which has the highest vaccination rate in the country, is seeing rising number of new cases, with an increasing number of infected people being fully vaccinated. In Europe, over the past week, the UK, Germany, Netherlands, and Denmark, all of which have higher vaccination rates than the US, are seeing their number of cases rise.

How should one hedge against a fifth COVID wave? Bonds should do better than stocks as the Fed might decide to postpone tapering. However, with inflationary pressure continuing to build, we are not in a bond friendly environment. If I am right about the coming fifth wave, the asset that will benefit most clearly is Pfizer stock.

PFE Weekly TTM
PFE Weekly TTM

Not only has it been found to be effective for adolescents, the FDA is currently reviewing the company's application for the agency's authorisation to use the vaccine as a 2-dose innoculation for children ages 5-11. That's in addition to the fact that a fifth wave will see increased demand for a third booster.

Plus, health regulators (and the market) might then very well think that an annual booster will be necessary. All this should help support Pfizer, especially given the stock is currently pricing a sharp drop in revenue in 2022.

I think the recent correction in Pfizer has created an attractive entry opportunity. I have been recommending it to the subscribers of my blog.

Full disclosure: I recently bought the stock at $42.

How To Hedge Your Investing Ahead Of COVID’s 5th Wave
 

Related Articles

How To Hedge Your Investing Ahead Of COVID’s 5th Wave

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
Mo Ahmadi
Mo Ahmadi Oct 23, 2021 10:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
not sure how you even allowed to publish this article here!! your analysis are truly so weak and based on nothing really and you have not even mentioned how so many different manufacturers (other than Pfizer) are coming up with effective and advance solutions?! so you wrote all these to recommend Pfizer as a hamper against the 5th wave?! really? I can name 10 other stocks which will do far better even under the senario you pointed here. really very weak analysis and sorry to be blunt.
Ad Wer
Ad Wer Oct 22, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Articles like these...🤮 the biggest lie of mankind 19 months underway
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email